John N Aucott Selected Research

Infections

4/2024	Autoantibodies in post-treatment Lyme disease and association with clinical symptoms.
8/2023	Outpatient visits before and after Lyme disease diagnosis in a Maryland employer-based health plan.
12/2021	Stages of Lyme Arthritis.
1/2018	Robust B Cell Responses Predict Rapid Resolution of Lyme Disease.
2/2016	Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease.
12/2015	Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.
11/2015	Quantification of Borrelia burgdorferi Membrane Proteins in Human Serum: A New Concept for Detection of Bacterial Infection.
1/2014	Serum inflammatory mediators as markers of human Lyme disease activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John N Aucott Research Topics

Disease

30	Lyme Disease (Disease, Lyme) 04/2024 - 08/2010
9	Post-Lyme Disease Syndrome 04/2024 - 12/2018
8	Infections 04/2024 - 01/2014
6	Erythema 01/2024 - 01/2012
4	Inflammation (Inflammations) 01/2022 - 01/2014
3	Pain (Aches) 01/2022 - 03/2017
3	Fatigue 01/2020 - 06/2015
2	Bacterial Infections (Bacterial Infection) 11/2022 - 11/2015
2	Tick-Borne Diseases (Tick-Borne Disease) 12/2020 - 02/2016
2	Exanthema (Rash) 12/2020 - 08/2012
1	COVID-19 04/2024
1	Necrosis 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Scleritis (Episcleritis) 01/2022
1	Multiple Sclerosis 01/2022
1	Neuromyelitis Optica (Devic's Disease) 01/2022
1	Arthritis (Polyarthritis) 12/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Cognitive Dysfunction 03/2017
1	Chronic Disease (Chronic Diseases) 02/2016
1	Musculoskeletal Pain 06/2015

Drug/Important Bio-Agent (IBA)

18	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 01/2012
7	AntibodiesIBA 04/2024 - 12/2015
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2014
3	Doxycycline (Periostat)FDA LinkGeneric 12/2021 - 03/2015
3	Immunoglobulin G (IgG)IBA 12/2015 - 08/2010
2	AutoantibodiesIBA 04/2024 - 01/2022
2	AntigensIBA 01/2018 - 12/2015
2	ChemokinesIBA 09/2016 - 01/2014
2	Membrane Proteins (Integral Membrane Proteins)IBA 12/2015 - 11/2015
1	Annexin A2 (Annexin II)IBA 01/2024
1	Protein-Arginine DeiminasesIBA 01/2022
1	mirfentanilIBA 01/2022
1	Amoxicillin (Wymox)FDA LinkGeneric 12/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2021
1	ORALIT (ORS)IBA 11/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	VaccinesIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	BuffersIBA 11/2019
1	Staphylococcal Protein A (Protein A)IBA 12/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2016
1	Peptides (Polypeptides)IBA 12/2015
1	Immunoglobulin M (IgM)IBA 12/2015
1	Bacterial Proteins (Bacterial Protein)IBA 11/2015
1	Chemokine ReceptorsIBA 01/2014
1	CytokinesIBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2012

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2012
7	Aftercare (After-Treatment) 08/2023 - 06/2015
2	Ambulatory Care (Outpatient Care) 08/2023 - 01/2020
2	Time-to-Treatment 01/2023 - 01/2020
1	Treatment Delay 01/2020